Luigi Grassi1, Luzia Travado, Francisco Luis Gil Moncayo, Silvana Sabato, Elena Rossi. 1. Department of Behaviour and Communication, Section of Psychiatry, University of Ferrara and Department of Mental Health and General University S. Anna Hospital, Corso Giovecca 203, 44100 Ferrara, Italy. luigi.grassi@unife.it
Abstract
BACKGROUND: A few and partial data are available on psychosocial morbidity among cancer patients in Mediterranean countries. As a part of a more general investigation (Southern European Psycho-Oncology Study-SEPOS), the rate of psychosocial morbidity and its correlation with clinical and cultural variables were examined in cancer patients in Italy, Portugal and Spain. METHODS: A convenience sample of cancer outpatients with good performance status and no cognitive impairment were approached. The Hospital Anxiety-Depression scale (HAD-S), the Mini-Mental Adjustment to Cancer scale (Mini-MAC), and the Cancer Worries Inventory (CWI) were used to measure psychological morbidity, coping strategies and concerns about illness. RESULTS: Of 277 patients, 34% had pathological scores ("borderline cases" plus "true cases") on HAD-S Anxiety and 24.9% on HAD-S Depression. Total psychiatric "caseness" was 28.5% and 16.6%, according to different HAD cut-offs (14 and 19, respectively). Significant relationships of HAD-S Anxiety, HAD-S Depression, HAD-S Total score, with Mini-MAC Hopeless and Anxious Preoccupation, and CWI score were found. No differences emerged between countries on psychosocial morbidity, while some differences emerged between the countries on coping mechanisms. Furthermore, Fatalism, Avoidance and marginally Hopeless were higher compared to studies carried out in English-speaking countries. LIMITATIONS: The relatively small sample size and the good performance status prevent us to generalize data on patients with different cancer sites and advanced phase of illness. CONCLUSIONS: One-third of the patients presented anxiety and depressive morbidity, with significant differences in characteristics of coping in Mediterranean countries in comparison with English-speaking countries.
BACKGROUND: A few and partial data are available on psychosocial morbidity among cancerpatients in Mediterranean countries. As a part of a more general investigation (Southern European Psycho-Oncology Study-SEPOS), the rate of psychosocial morbidity and its correlation with clinical and cultural variables were examined in cancerpatients in Italy, Portugal and Spain. METHODS: A convenience sample of cancer outpatients with good performance status and no cognitive impairment were approached. The Hospital Anxiety-Depression scale (HAD-S), the Mini-Mental Adjustment to Cancer scale (Mini-MAC), and the Cancer Worries Inventory (CWI) were used to measure psychological morbidity, coping strategies and concerns about illness. RESULTS: Of 277 patients, 34% had pathological scores ("borderline cases" plus "true cases") on HAD-S Anxiety and 24.9% on HAD-S Depression. Total psychiatric "caseness" was 28.5% and 16.6%, according to different HAD cut-offs (14 and 19, respectively). Significant relationships of HAD-S Anxiety, HAD-S Depression, HAD-S Total score, with Mini-MAC Hopeless and Anxious Preoccupation, and CWI score were found. No differences emerged between countries on psychosocial morbidity, while some differences emerged between the countries on coping mechanisms. Furthermore, Fatalism, Avoidance and marginally Hopeless were higher compared to studies carried out in English-speaking countries. LIMITATIONS: The relatively small sample size and the good performance status prevent us to generalize data on patients with different cancer sites and advanced phase of illness. CONCLUSIONS: One-third of the patients presented anxiety and depressive morbidity, with significant differences in characteristics of coping in Mediterranean countries in comparison with English-speaking countries.
Authors: Francisco Gil; Luigi Grassi; Luzia Travado; Michele Tomamichel; Juan Ramón Gonzalez Journal: Support Care Cancer Date: 2005-03-11 Impact factor: 3.603
Authors: Cristina Civilotti; Daniela Acquadro Maran; Francesca Santagata; Antonella Varetto; Maria Rosa Stanizzo Journal: Support Care Cancer Date: 2020-02-08 Impact factor: 3.603
Authors: I Ghanem; B Castelo; P Jimenez-Fonseca; A Carmona-Bayonas; O Higuera; C Beato; T García; R Hernández; C Calderon Journal: Clin Transl Oncol Date: 2019-05-10 Impact factor: 3.405
Authors: P Jimenez-Fonseca; C Calderon; A Carmona-Bayonas; M M Muñoz; R Hernández; M Mut Lloret; I Ghanem; C Beato; D Cacho Lavín; A Ivars Rubio; R Carrión; C Jara Journal: Clin Transl Oncol Date: 2018-04-02 Impact factor: 3.405
Authors: Janice A Blalock; Cho Lam; Jennifer A Minnix; Maher Karam-Hage; Ellen R Gritz; Jason D Robinson; Paul M Cinciripini Journal: J Cogn Psychother Date: 2011
Authors: V Strong; R Waters; C Hibberd; R Rush; A Cargill; D Storey; J Walker; L Wall; M Fallon; M Sharpe Journal: Br J Cancer Date: 2007-02-20 Impact factor: 7.640